Cingulate Inc. (CING) stock
CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
$4.64+0.08 (+1.75%)
Close on Nov 11, 2026Market cap $67.47MP/E –Yield –
Cingulate total assets
Total assets on the balance sheet at the end of each period.
Cingulate's total assets was $33.07M at Jun 30, 2026. For fiscal 2025 it was $15.07M, up 1.4% from the year before. The highest annual figure on record is $22.89M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.07M | +1.4% |
| FY2024 | Dec 31, 2024 | $14.86M | +325.7% |
| FY2023 | Dec 31, 2023 | $3.49M | -69.4% |
| FY2022 | Dec 31, 2022 | $11.41M | -50.2% |
| FY2021 | Dec 31, 2021 | $22.89M | +295.4% |
| FY2020 | Dec 31, 2020 | $5.79M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $33.07M | +145.5% |
| Q1 FY2026 | Mar 31, 2026 | $30.86M | +147.5% |
| Q4 FY2025 | Dec 31, 2025 | $15.07M | +1.4% |
| Q3 FY2025 | Sep 30, 2025 | $10.52M | -22.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.47M | +145.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.47M | +257.1% |
| Q4 FY2024 | Dec 31, 2024 | $14.86M | +153.2% |
| Q3 FY2024 | Sep 30, 2024 | $13.58M | +159.8% |
| Q1 FY2024 | Mar 31, 2024 | $5.49M | -23.3% |
| Q4 FY2023 | Dec 31, 2023 | $3.49M | -69.4% |
| Q3 FY2023 | Sep 30, 2023 | $5.87M | -61.8% |
| Q2 FY2023 | Jun 30, 2023 | $5.23M | -62.1% |
| Q1 FY2023 | Mar 31, 2023 | $7.16M | -61.1% |
| Q4 FY2022 | Dec 31, 2022 | $11.41M | -50.2% |
| Q3 FY2022 | Sep 30, 2022 | $15.38M | +165.7% |
| Q2 FY2022 | Jun 30, 2022 | $13.80M | – |
| Q1 FY2022 | Mar 31, 2022 | $18.43M | – |
| Q4 FY2021 | Dec 31, 2021 | $22.89M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.79M | – |
See a number that looks wrong?